StockData
PAVmed Inc. logo

PAVmed Inc. (PAVM) stock

PAVMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$1.51−0.24 (-13.71%)

Close on Nov 17, 2026Market cap $12.07MP/E –Yield –

PAVmed price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

PAVmed's price to sales ratio was 89.8× on Nov 11, 2026, against 293.3× a year earlier. Over the last 5 years it ranged from 1.7× to 457.2×, with a median of 59.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202689.8×−85.7
2025Dec 31, 2025175.5×+173.9
2024Dec 31, 20241.7×−20.0
2023Dec 29, 202321.7×−56.7
2022Dec 30, 202278.4×–

More PAVmed figures

See a number that looks wrong?